Altered cholesterol and fatty acid metabolism in Huntington disease - Wikidata - awgldk - TriplyDB

Altered cholesterol and fatty acid metabolism in Huntington disease

Altered cholesterol and fatty acid metabolism in Huntington disease

http://www.wikidata.org/entity/Q34080706

about

Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System Maintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunction Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease.Area per lipid and cholesterol interactions in membranes from separated local-field (13)C NMR spectroscopy Cholesterol metabolism and homeostasis in the brain Impact of cholesterol on disease progression Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis Cholesterol: its regulation and role in central nervous system disorders.A Metabolic Study of Huntington's Disease.Beyond the redox imbalance: Oxidative stress contributes to an impaired GLUT3 modulation in Huntington's disease Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.Mechanism(s) of alteration of micro RNA expressions in Huntington's disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease.LXR agonists: new potential therapeutic drug for neurodegenerative diseases.Model cell membranes: Techniques to form complex biomimetic supported lipid bilayers via vesicle fusion.Lipid rafts in neurodegeneration and neuroprotection.Lipid metabolism in Alzheimer's disease Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime.Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer Disease and other neurodegenerative diseases: An in silico-updated overview.Revealing disease-associated pathways by network integration of untargeted metabolomics.Epidemiology of stroke in Finnish patients with Huntington's disease.Whole gene expression profile in blood reveals multiple pathways deregulation in R6/2 mouse model.Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid.High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson's Disease Patients.Towards an Understanding of Energy Impairment in Huntington's Disease Brain.Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles.Analysis of the protein network of cholesterol homeostasis in different brain regions: an age and sex dependent perspective.Alteration in Fluidity of Cell Plasma Membrane in Huntington Disease Revealed by Spectral Phasor Analysis.Oleic Acid and Hydroxytyrosol Inhibit Cholesterol and Fatty Acid Synthesis in C6 Glioma Cells.Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington's Disease.Extremely low frequency electromagnetic field exposure and restraint stress induce changes on the brain lipid profile of Wistar rats.Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model.Dysregulation of Neuronal Cholesterol Homeostasis upon Exposure to HIV-1 Tat and Cocaine Revealed by RNA-Sequencing

P2860

Q26999386-4E0C8B76-E9CA-4FC3-AF72-1D90ACF6DE3F Q27341821-63EBBC5A-091F-47A4-B1F5-BF0BBA8145AF Q33902931-39396D63-4CE4-479A-A5C6-5E5F7E839755 Q34561311-5F11098D-6843-495E-912C-EB626711743D Q35252263-D32A29CC-EE98-4885-9059-CDC285300847 Q35850911-26131DE3-6088-4A09-879D-7156BD4170F5 Q36284241-14D007F9-65C4-49CF-BC16-A21602D10AB8 Q36355194-D985E21F-4765-45CA-B0E3-98D4345C9E0A Q36445216-44FCAFFB-D13A-4D61-B426-07382D9A1A1C Q36824396-BE18B5C1-B957-464B-B97B-6B3002079363 Q37014362-975C9380-679E-4F2A-8853-F716D9CB7996 Q37707514-B76E3692-F607-4038-8294-2FB6DB653204 Q38009700-17C75C84-4456-4277-9A89-58D1EBADA621 Q38102608-FBC35506-C916-4385-A6FC-180D71392886 Q38137053-F4913B65-2D52-4ABA-B160-22630E85578F Q38173298-BE57E44E-0357-46DC-A7F9-BDDCE9ECEA45 Q38204719-70B0D602-C8F7-4A59-A290-53AB97BA6AC7 Q39014966-183A2865-4195-4D4F-A5A7-A42F84A2065A Q39121710-2B63EFD8-51F2-42BA-AAAE-B16B2183A523 Q39538215-4CE36E0B-B4BF-4BBF-8A62-238AE5343CD2 Q40505097-A0287174-9906-4D26-B495-2908C89F7045 Q42918972-7F177599-CFF8-4BEF-A5F4-CEED947AD403 Q45290056-D1FF8CB0-ED6A-4720-B26F-AFF7AEC8E7DE Q45290192-B0B30ADC-0DC9-497F-BDBE-03971F95ED75 Q46264470-9A819A7E-96F0-4629-8848-346C0595D099 Q47442924-0B34F070-C2F5-4124-B8F4-0826F8A287BB Q47836666-4797C446-6E53-456B-9600-99C211786831 Q48229956-2F7AD155-E5AD-446C-AF9E-7F18232612C4 Q49475422-71045003-DF2C-4B3D-9A92-43C2B7D9C91E Q49784908-7F02E61F-605B-481E-99A6-60BDDA35DE27 Q55295842-15F8E10B-F448-443A-8124-BCFEFC9E67D9 Q55384569-73758941-6787-4FDC-9F28-956B46B29465 Q55497345-0CF00BDC-EA3D-45F1-95D3-DF39D960287C Q58618180-4557C74F-7AD1-424A-A70D-252B677FE1C5

P2860

Altered cholesterol and fatty acid metabolism in Huntington disease

http://www.wikidata.org/entity/Q34080706

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Altered cholesterol and fatty acid metabolism in Huntington disease

@ast

Altered cholesterol and fatty acid metabolism in Huntington disease

@en

Altered cholesterol and fatty acid metabolism in Huntington disease

@nl

type

label

Altered cholesterol and fatty acid metabolism in Huntington disease

@ast

Altered cholesterol and fatty acid metabolism in Huntington disease

@en

Altered cholesterol and fatty acid metabolism in Huntington disease

@nl

prefLabel

Altered cholesterol and fatty acid metabolism in Huntington disease

@ast

Altered cholesterol and fatty acid metabolism in Huntington disease

@en

Altered cholesterol and fatty acid metabolism in Huntington disease

@nl

P1433

Q34080706-C6CBB4A5-B1EB-4C13-A579-1CAB34C909E4

P1476

Q34080706-95033241-17B5-4930-BED5-66A371F6BD2A

P2093

Q34080706-1DB0B113-0FE0-464B-83E5-98AA0FC0FDBE

Q34080706-2607F15A-391E-4287-B3DB-29E55681DF81

Q34080706-282E5624-DE45-4D97-AF79-895CEEC767FC

Q34080706-DCD02442-E874-43A0-924D-E3C03E382D21

Q34080706-FF68B23D-C538-49BF-893A-C8A2B2F08CCC

P2860

Q34080706-0E5C00FE-D66E-4621-A41B-14B92F4328B4

Q34080706-1407B188-3E6F-488B-A27F-D7C344F883FC

Q34080706-162B348F-722E-499B-8291-A1E454987EF6

Q34080706-184D3D10-5882-42FB-8AAB-7CC88E35E3E3

Q34080706-1E06590B-55B4-4AA5-AB3C-B438906A762C

Q34080706-236C0E49-FEB6-496A-9639-82B7D7327C7B

Q34080706-24966A77-8EF2-4011-924B-44C7968E2BB1

Q34080706-2DD6A510-0666-4FE8-8F0B-97F47022B21F

Q34080706-3A329C69-1DD2-41FD-89F3-405F99E3EDB5

Q34080706-404264B5-F2FD-479A-8BA9-004E8C4458EF

P304

Q34080706-DCC2C9B6-3A95-44D2-859D-2835F514285D

P31

Q34080706-CEDFD04D-E333-42DA-8EF7-B2668954EC49

P356

Q34080706-04711CBF-B439-4A85-81AC-07778E66CC2A

P407

Q34080706-C2A56FB7-101B-4DD9-87A4-9F40030FB1EA

P433

Q34080706-832F8BD6-BBA6-4519-A198-F1FB0B3DCCB8

P478

Q34080706-588DE72B-DCE1-47ED-AE80-D763E46C9BC6

P577

Q34080706-C74FC5EE-D4D5-4805-8915-6F83BDC3F12E

P5875

Q34080706-99D36800-6CBD-43A3-8DB4-C48FC34FA501

P698

Q34080706-ABF3025C-C6BF-494D-AA23-B740116C977E

P921

Q34080706-78AFBE8E-4D5C-4B1C-B2D5-5DE889A2A77B

Q34080706-A93FA119-6179-4D13-A312-E28373C352E7

P932

Q34080706-40869F54-B064-49A6-A9D6-966C42B87FA3

P356

J.JACL.2009.11.003

P1433

Journal of Clinical Lipidology

P1476

Altered cholesterol and fatty acid metabolism in Huntington disease

@en

P2093

Christopher A Beck

http://www.w3.org/2001/XMLSchema#string

E Ray Dorsey

http://www.w3.org/2001/XMLSchema#string

Ira Shoulson

http://www.w3.org/2001/XMLSchema#string

J Thomas Brenna

http://www.w3.org/2001/XMLSchema#string

Robert C Block

http://www.w3.org/2001/XMLSchema#string

P2860

Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function

The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

Inhibition by eicosapentaenoic acid of IL-1beta-induced PGHS-2 expression in human microvascular endothelial cells: involvement of lipoxygenase-derived metabolites and p38 MAPK pathway

HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals.

n-3 fatty acids and serum lipoproteins: human studies.

P304

17-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACL.2009.11.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46037095

http://www.w3.org/2001/XMLSchema#string

P698

20802793

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

2926984

http://www.w3.org/2001/XMLSchema#string